Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice

被引:251
作者
Dupuis, M
Denis-Mize, K
Woo, C
Goldbeck, C
Selby, MJ
Chen, MC
Otten, GR
Ulmer, JB
Donnelly, JJ
Ott, G
McDonald, DM
机构
[1] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Chiron Vaccines, Emeryville, CA 94608 USA
关键词
D O I
10.4049/jimmunol.165.5.2850
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Intramuscular injection of DNA vaccines elicits potent humoral and cellular immune responses in mice. However, DNA vaccines are less efficient in larger animal models and humans. To gain a better understanding of the factors limiting the efficacy of DNA vaccines, we used fluorescence-labeled plasmid DNA in mice to 1) define the macroscopic and microscopic distribution of DNA after injection into the tibialis anterior muscle, 2) characterize cellular uptake and expression of DIVA in muscle and draining lymph nodes, and 3) determine the effect of modifying DNA distribution and cellular uptake by volume changes or electroporation on the magnitude of the immune response. Injection of a standard 50-mul dose resulted in the rapid dispersion of labeled DNA throughout the muscle. DNA was internalized within 5 min by muscle cells near the injection site and over several hours by cells that were located along muscle fibers and in the draining lymph nodes. Histochemical staining and analysis of mRNA expression in isolated cells by RT-PCR showed that the transgene was detectably expressed only by muscle cells, despite substantial DNA uptake by non-muscle cells. Reduction of the injection volume to 5 mul resulted in substantially less uptake and expression of DNA by muscle cells, and correspondingly lower immune responses against the transgene product. However, expression and immunogenicity were restored when the 5-mul injection was followed by electroporation in vivo, These findings indicate that distribution and cellular uptake significantly affect the immunogenicity of DNA vaccines.
引用
收藏
页码:2850 / 2858
页数:9
相关论文
共 45 条
  • [1] DNA vaccination: Transfection and activation of dendritic cells as key events for immunity
    Akbari, O
    Panjwani, N
    Garcia, S
    Tascon, R
    Lowrie, D
    Stockinger, B
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) : 169 - 177
  • [2] Bouloc A, 1999, EUR J IMMUNOL, V29, P446, DOI 10.1002/(SICI)1521-4141(199902)29:02<446::AID-IMMU446>3.0.CO
  • [3] 2-A
  • [4] Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients
    Calarota, S
    Bratt, G
    Nordlund, S
    Hinkula, J
    Leandersson, AC
    Sandström, E
    Wahren, B
    [J]. LANCET, 1998, 351 (9112) : 1320 - 1325
  • [5] Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope
    Casares, S
    Inaba, K
    Brumeanu, TD
    Steinman, RM
    Bona, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) : 1481 - 1486
  • [6] Chattergoon MA, 1998, J IMMUNOL, V160, P5707
  • [7] CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
    Chu, RS
    Targoni, OS
    Krieg, AM
    Lehmann, PV
    Harding, CV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) : 1623 - 1631
  • [8] DNA-based immunization by in vivo transfection of dendritic cells
    Condon, C
    Watkins, SC
    Celluzzi, CM
    Thompson, K
    Falo, LD
    [J]. NATURE MEDICINE, 1996, 2 (10) : 1122 - 1128
  • [9] Corr M, 1999, J IMMUNOL, V163, P4721
  • [10] Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
    Corr, M
    Lee, DJ
    Carson, DA
    Tighe, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1555 - 1560